Dashboard
Manage Tickers

IMUXIMMUNIC, INC.

Nasdaq immunic-therapeutics.com


$ 1.58 $ 0.09 (6.04 %)    

Tuesday, 20-Aug-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 480.64 $ -0.66 (-0.14 %)
DIA $ 408.54 $ -0.35 (-0.09 %)
SPY $ 558.65 $ -0.51 (-0.09 %)
TLT $ 98.68 $ 0.38 (0.39 %)
GLD $ 232.46 $ -1.26 (-0.54 %)
$ 1.49
$ 1.50
$ 1.56 x 600
$ 1.58 x 167
$ 1.50 - $ 1.58
$ 0.95 - $ 1.92
285,508
na
150.9M
$ 1.45
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 02-22-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 02-23-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 02-24-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-06-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 02-26-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 08-03-2020 06-30-2020 10-Q
18 05-08-2020 03-31-2020 10-Q
19 03-16-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 04-10-2019 03-31-2019 10-Q
23 03-04-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-07-2018 06-30-2018 10-Q
26 05-08-2018 03-31-2018 10-Q
27 03-13-2018 12-31-2017 10-K
28 10-25-2017 09-30-2017 10-Q
29 08-03-2017 06-30-2017 10-Q
30 05-09-2017 03-31-2017 10-Q
31 03-07-2017 12-31-2016 10-K
32 11-03-2016 09-30-2016 10-Q
33 08-02-2016 06-30-2016 10-Q
34 05-09-2016 03-31-2016 10-Q
35 03-08-2016 12-31-2015 10-K
36 11-05-2015 09-30-2015 10-Q
37 08-06-2015 06-30-2015 10-Q
38 05-12-2015 03-31-2015 10-Q
39 03-20-2015 12-31-2014 10-K
40 11-13-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

immunic-q2-eps-021-beats-024-estimate-exits-quarter-with-cash--equivalents-worth-79698m
Immunic Q2 EPS $(0.21) Beats $(0.24) Estim...
08/08/2024 10:35:01

Immunic (NASDAQ:IMUX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.23) by 8....

piper-sandler-reiterates-overweight-on-immunic-maintains-28-price-target
Piper Sandler Reiterates Overweight on Imm...
07/16/2024 15:44:26

Piper Sandler analyst Yasmeen Rahimi reiterates Immunic (NASDAQ:IMUX) with a Overweight and maintains $28 price target.

immunic-says-jason-tardio-will-be-joining-company-as-coo-and-president-effective-july-12-2024
Immunic Says Jason Tardio Will Be Joining ...
07/09/2024 10:33:48

The company also reported that Werner Gladdines, current Vice President, Program Management & Clinical Development Operatio...

immunic-raises-size-of-mixed-shelf-offering-from-250m-to-4123m
Immunic Raises Size Of Mixed Shelf Offerin...
05/24/2024 20:21:29

https://www.sec.gov/Archives/edgar/data/1280776/000119380524000704/e663650_s3a-immunic.htm 

immunic-says-it-bolstered-balance-sheet-through-three-tranche-private-placement-totaling-up-to-240m-extending-cash-runway-into-q3-2025-based-on-initial-80m-tranche
Immunic Says It Bolstered Balance Sheet Th...
05/08/2024 10:53:20

immunic-q1-eps-030-misses-026-estimate-cash-and-equivalents-as-of-march-31-2024-were-973m
Immunic Q1 EPS $(0.30) Misses $(0.26) Esti...
05/08/2024 10:33:07

Immunic (NASDAQ:IMUX) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.26) by ...

immunic-announces-publication-of-extended-data-from-phase-2-emphasis-trial-of-vidofludimus-calcium-in-relapsing-remitting-multiple-sclerosis-in-neurology-neuroimmunology--neuroinflammation
Immunic Announces Publication of Extended ...
04/30/2024 10:32:02

30 mg and 45 mg Daily Doses of Vidofludimus Calcium Suppressed Development of Gadolinium-Enhancing Lesions by 78% and 74% Com...

brookline-capital-initiates-coverage-on-immunic-with-buy-rating-announces-price-target-of-10
Brookline Capital Initiates Coverage On Im...
04/05/2024 08:59:32

Brookline Capital analyst Tyler Bussian initiates coverage on Immunic (NASDAQ:IMUX) with a Buy rating and announces Price Ta...

immunic-has-received-a-notice-of-allowance-from-united-states-patent-and-trademark-office-for-patent-covering-composition-of-matter-of-vidofludimus-calcium-imu-838-and-related-production-method-expected-to-provide-protection-into-2039
Immunic Has Received A Notice Of Allowance...
03/20/2024 10:33:36

immunic-and-2-other-stocks-under-2-insiders-are-buying
Immunic And 2 Other Stocks Under $2 Inside...
02/29/2024 15:40:09

The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their conf...

immunic-announced-the-presentation-of-data-from-its-phase-2-calliper-and-calvid-1-trials-of-lead-asset-vidofludimus-calcium-imu-838-at-the-americas-committee-for-treatment-and-research-in-multiple-sclerosis-forum-2024
Immunic Announced The Presentation Of Data...
02/29/2024 11:32:15

immunic-q4-eps-048-beats-051-estimate-cash-and-equivalents-as-of-december-31-2023-were-467m
Immunic Q4 EPS $(0.48) Beats $(0.51) Estim...
02/22/2024 11:37:32

Immunic (NASDAQ:IMUX) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.51) by 5....

earnings-scheduled-for-february-22-2024
Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

immunics-earnings-outlook
Immunic's Earnings Outlook
02/21/2024 19:02:50

whats-going-on-with-immunic-stock
What's Going On With Immunic Stock?
01/05/2024 17:03:42

Immunic, Inc. (NASDAQ: IMUX) shares are roughly flat following strength early Friday after the company announced a three-tranch...

Core News & Articles
Market-Moving News for January 5th
01/05/2024 13:53:53

IMUX: 54% | Immunic, Inc. Announces Private Placement of up to $240M DZSI: 35% | DZS Secures $25M In Funding And Signs Definit...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
01/05/2024 13:05:58

immunic-inc-announces-private-placement-of-up-to-240m
Immunic, Inc. Announces Private Placement ...
01/05/2024 11:31:55

Immunic, Inc. (NASDAQ:IMUX) ("Immunic" or the "Company"), a biotechnology company developing a clinical pipelin...

immunic-receives-notice-of-allowance-for-us-patent-protecting-vidofludimus-calciums-dosing-regimens-in-multiple-sclerosis
Immunic Receives Notice of Allowance for U...
11/21/2023 11:31:59

 Immunic, Inc. (NASDAQ:IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule the...

earnings-scheduled-for-november-14-2023
Earnings Scheduled For November 14, 2023
11/14/2023 13:23:43

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION